Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Christopher J. Logothetis
Based on 132 articles published since 2007
||||
Expertise Level
The expertise of Christopher J. Logothetis ranks in the
  • Top 0.021%
  • ... of 132,893 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 132 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Logothetis, C J   ·   Logothetis, Chris   ·   Logothetis, C   ·   Logothetis, Christopher   ·   Logothetis, Christopher J
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • From the University of Texas M.D. Anderson Cancer Center, Houston. · Pubmed 28745978
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE, B4301, Atlanta, GA, 30322, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-3721, USA. · Pubmed 28730293
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Taipei Medical University and Hospital, Taipei 110, Taiwan. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, McGill University, Montreal, QC, H3A 1G1, Canada. · Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 28586644
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · ORBIT (Oncology Research for Biologics and Immunotherapy Translation), The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Pubmed 28536297
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson &Johnson, Spring House, Pennsylvania, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 28346412
  • Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Viterbi School of Engineering, University of Southern California, Los Angeles, California. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27702818
2016
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. · Department of Urology and. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 27515962
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Oncology, Alexandra Hospital, University of Athens, Athens, Greece. · Pubmed 27748439
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Adaptive Biotechnologies, Seattle, WA 98102. · Adaptive Biotechnologies, Seattle, WA 98102; Fred Hutchinson Cancer Research Center, Seattle, WA 98102. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Pubmed 27698113
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Pubmed 27599544
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Current address: General Internal Medicine Section, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA. · Current address: Infectious Diseases Division, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 27331874
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Urology, The University of Texas Southwestern Medical School, Dallas, TX 75390, USA. · Department of Urology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA. · Moores Cancer Center, University of California, San Diego, San Diego, CA 92093, USA. · Pubmed 27322462
  • Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan. · Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA. · Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA. · Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. · Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Molecular Carcinogenesis, Science Park, UT MD Anderson Cancer Center, Smithville, TX, USA. · Metastasis Research Center, UT MD Anderson Cancer Center, Houston, TX, USA. · Center for Stem Cell and Developmental Biology, UT MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26804168
  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biological Science, College of Natural Sciences, Wonkwang University, Cheonbuk, Iksan, South Korea. · Sanofi Oncology, Cambridge, Massachusetts. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26701088
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Human and Molecular Genetics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Clinical and Translational Sciences Graduate Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Pubmed 26546618
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Imaging Physics-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Pubmed 26272062
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26059275
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. · Pubmed 25714186
2015
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Urology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Pubmed 26171883
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Alvos Therapeutics, Arrowhead Research Corporation, Pasadena, California. · Pubmed 25832466
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan. · Department of Genetics, Center for Cancer Genetics and Genomics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medicine, Baylor College of Medicine, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26530902
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Pubmed 26515605
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Candiolo Cancer Institute and Department of Oncology, University of Turin, Candiolo 10060, Italy; · University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · Human Genetics Foundation, Torino 10126, Italy; · Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Ludwig Institute for Cancer Research, University of California-San Diego, La Jolla, CA 92093; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; Institute of Psychiatry, University of São Paulo Medical School, São Paulo 01060, Brazil · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Pubmed 26080435
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • David H. Koch Center, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; · University of New Mexico Cancer Center and Divisions of Molecular Medicine and. · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215 · University of New Mexico Cancer Center and Divisions of Molecular Medicine and · University of New Mexico Cancer Center and Hematology and Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; and · Pubmed 25762070
  • From the Departments of ‡Translational Molecular Pathology. · ‖Department of Chemistry, Josip Juraj Strossmayer University, 31000 Osijek, Croatia; · ****Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia; · ‡‡Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02903. · §Genitourinary Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX; · ¶Department of Medicine, Baylor College of Medicine, Houston, Texas 77030; · From the Departments of ‡Translational Molecular Pathology, · Pubmed 25527621
2014
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25274378
  • Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. The Rolanette and Berdon Lawrence Bone Disease Program of Texas, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Athens Greece School of Medicine, Athens 11528, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biological Chemistry, University of Buenos Aires-National Research Council of Argentina (CONICET-IQUIBICEN), Ciudad Autonoma de Buenos Aires C1428EGA, Argentina. · Center for Cancer and Stem Cell Biology, IBT-Texas A&M Health Science Center, Houston, TX 77030, USA. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25186177
  • From the Departments of Genitourinary Medical Oncology, Radiation Oncology, Urology, and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24994920
  • University of Texas, M D Anderson Cancer Center, Genitourinary Medical Oncology, Holcombe Blvd, Houston, TX 77030, USA. Electronic address: · Pubmed 24836275
2013
  • Departments of 1Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23811619
  • Industrial Center, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China ; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · School of Computer Science and Technology, Soochow University, Suzhou 215006, China. · School of Applied Chemistry and Biotechnology, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China. · Pubmed 24367394
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23707438
2012
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23142059
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22093188
2011
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA. · Pubmed 21592278
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Pubmed 21456067
2008
  • The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 18487561
  • Department of GU Medical Oncology UT, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 18497043
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 18347159
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19138948
2017
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia; Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland; Josep M. Piulats, Institut Català d'Oncologia, Barcelona; Javier Puente, Hospital Clínico San Carlos, Madrid, Spain; Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar; Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile; Dirk Jaeger, University Hospital, Heidelberg, Germany; Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil; Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico; Lisa Sengeløv, Herlev Hospital, Herlev, Denmark; M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT; Arvind Varma, DOCS Inc, New York, NY; Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam; and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25155428
2014
  • Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 24727321
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 25347368
  • Authors' Affiliations: Michigan Center for Translational Pathology; Departments of Pathology, Radiation Oncology, Internal Medicine, Pharmacology, and Urology; Comprehensive Cancer Center; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas; Department of Urology, Institute of Prostate Cancer and LeFrak Center For Robotic Surgery; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York Presbyterian Hospitals, New York, New York; Departments of Cancer Biology, Urology, and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania; and Centre for Integrative Biology, University of Trento, Trento, Italy. · Pubmed 24473064
2013
  • Department of Genitourinary Medical Onology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 24211163
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-3721, USA. · Pubmed 23649003
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 23526299
  • UT MD Anderson Cancer Center, Genitourinary Medical Oncology, Houston, Texas 77030, USA. · Pubmed 23371521
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23339185
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 23102837
2012
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1374, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 22184395
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21976132
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030-4009, USA. · Pubmed 21821830
  • Department of Genitourinary Medical Oncology and David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23300537
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23166609
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Houston, TX 77230, USA. · Pubmed 23033003
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA. · Pubmed 22809348
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Box 1374, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22805323
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22593245
  • Department of Genitourinary Medical Oncology, The David Koch Center for Applied Research of Genitourinary Cancers, The Stanford Alexander Tissue Derivatives Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22457212
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22156612
  • Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21681775
2011
  • University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Clinical Research Building (T7.3891), 1515 Holcombe Blvd, Unit 0018-4, Houston, TX 77030, USA. · Pubmed 22035268
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 21917607
  • The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030-3721, USA. · Pubmed 21606419
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22586648
  • Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Pubmed 22194926
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 21707705
2010
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20551894
  • Department of Genitourinary Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19581923
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21044312
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20564322
  • Departments of Molecular Pathology, Genitourinary Medical Oncology, and System Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20484040
  • Department of Genitourinary Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20386565
  • University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19853370
2009
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77239-1439, USA. · Pubmed 19414670
  • Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19244175
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19855158
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 19652704
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 19551858
  • Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19202079
2008
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, 1155 Pressler, CPB7.3462, Houston, TX 77030, USA. · Pubmed 19029421
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, 1155 Pressler, Houston, TX 77030, USA. · Pubmed 18841158
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18708358
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 18618013
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18559590
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18490922
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 17700537
2007
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3721, USA. · Pubmed 17879948
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 17317833
  • Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17971530
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 17908974
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 17638862
Probable:    University of Athens      
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
2013
  • Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Pubmed 22753310
2010
  • Department of Genitourinary Medical Oncology and David H Koch Center for Applied Research of Genitourinary Cancers, University of Athens, Athens, Greece. · Pubmed 20145177
Probable:    Miscellaneous institutions in Houston      
2015
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. Electronic address: · Pubmed 24882673
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 132 total) written by Christopher J. Logothetis about Prostatic Neoplasms:

  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Improved Outcomes in Men with Advanced Prostate Cancer. 2017
  • Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. 2017
  • Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy. 2017
  • Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. 2017
  • Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer. 2017
  • VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. 2017
  • Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters. 2017
  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. 2016
  • Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance. 2016
Show List of Full Article Records
Google Searches

Learn more about Christopher J. Logothetis using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
University of Athens
Miscellaneous institutions in Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • From the University of Texas M.D. Anderson Cancer Center, Houston. · Pubmed 28745978
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, 1365 Clifton Road NE, B4301, Atlanta, GA, 30322, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-3721, USA. · Pubmed 28730293
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Taipei Medical University and Hospital, Taipei 110, Taiwan. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, McGill University, Montreal, QC, H3A 1G1, Canada. · Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 28586644
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · ORBIT (Oncology Research for Biologics and Immunotherapy Translation), The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Pubmed 28536297
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson &Johnson, Spring House, Pennsylvania, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 28346412
  • Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California. · Viterbi School of Engineering, University of Southern California, Los Angeles, California. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27702818
2016
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. · Department of Urology and. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 27515962
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Oncology, Alexandra Hospital, University of Athens, Athens, Greece. · Pubmed 27748439
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Adaptive Biotechnologies, Seattle, WA 98102. · Adaptive Biotechnologies, Seattle, WA 98102; Fred Hutchinson Cancer Research Center, Seattle, WA 98102. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 · Pubmed 27698113
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Dan L. Duncan Building (CPB7.3476), 1515 Holcombe Blvd., Unit 1374, Houston, TX, 77030, USA. · Pubmed 27599544
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Current address: General Internal Medicine Section, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA. · Current address: Infectious Diseases Division, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 27331874
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA. · Department of Urology, The University of Texas Southwestern Medical School, Dallas, TX 75390, USA. · Department of Urology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA. · Moores Cancer Center, University of California, San Diego, San Diego, CA 92093, USA. · Pubmed 27322462
  • Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan. · Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA. · Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA. · Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. · Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Molecular Carcinogenesis, Science Park, UT MD Anderson Cancer Center, Smithville, TX, USA. · Metastasis Research Center, UT MD Anderson Cancer Center, Houston, TX, USA. · Center for Stem Cell and Developmental Biology, UT MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26804168
  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biological Science, College of Natural Sciences, Wonkwang University, Cheonbuk, Iksan, South Korea. · Sanofi Oncology, Cambridge, Massachusetts. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26701088
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Human and Molecular Genetics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Clinical and Translational Sciences Graduate Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. · Pubmed 26546618
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Imaging Physics-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Programs in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. · Pubmed 26272062
  • Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26059275
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. · Pubmed 25714186
2015
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Urology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. · Pubmed 26171883
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Veterinary Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Alvos Therapeutics, Arrowhead Research Corporation, Pasadena, California. · Pubmed 25832466
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan. · Department of Genetics, Center for Cancer Genetics and Genomics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medicine, Baylor College of Medicine, Houston, Texas. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26530902
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Pubmed 26515605
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Candiolo Cancer Institute and Department of Oncology, University of Turin, Candiolo 10060, Italy; · University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; · Human Genetics Foundation, Torino 10126, Italy; · Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030; · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · Ludwig Institute for Cancer Research, University of California-San Diego, La Jolla, CA 92093; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; International Research Center, A.C. Camargo Cancer Center, São Paulo, SP 01508-010 Brazil; Institute of Psychiatry, University of São Paulo Medical School, São Paulo 01060, Brazil · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; · David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030; Division of Hematology/Oncology, University of New Mexico School of Medicine, Albuquerque, NM 87131; · Pubmed 26080435
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • David H. Koch Center, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; · University of New Mexico Cancer Center and Divisions of Molecular Medicine and. · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215 · University of New Mexico Cancer Center and Divisions of Molecular Medicine and · University of New Mexico Cancer Center and Hematology and Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; and · Pubmed 25762070
  • From the Departments of ‡Translational Molecular Pathology. · ‖Department of Chemistry, Josip Juraj Strossmayer University, 31000 Osijek, Croatia; · ****Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia; · ‡‡Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02903. · §Genitourinary Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX; · ¶Department of Medicine, Baylor College of Medicine, Houston, Texas 77030; · From the Departments of ‡Translational Molecular Pathology, · Pubmed 25527621
2014
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25274378
  • Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. The Rolanette and Berdon Lawrence Bone Disease Program of Texas, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Athens Greece School of Medicine, Athens 11528, Greece. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biological Chemistry, University of Buenos Aires-National Research Council of Argentina (CONICET-IQUIBICEN), Ciudad Autonoma de Buenos Aires C1428EGA, Argentina. · Center for Cancer and Stem Cell Biology, IBT-Texas A&M Health Science Center, Houston, TX 77030, USA. · Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25186177
  • From the Departments of Genitourinary Medical Oncology, Radiation Oncology, Urology, and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24994920
  • University of Texas, M D Anderson Cancer Center, Genitourinary Medical Oncology, Holcombe Blvd, Houston, TX 77030, USA. Electronic address: · Pubmed 24836275
2013
  • Departments of 1Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23811619
  • Industrial Center, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China ; Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. · School of Computer Science and Technology, Soochow University, Suzhou 215006, China. · School of Applied Chemistry and Biotechnology, Shenzhen Polytechnic, Shenzhen, Guangdong 518055, China. · Pubmed 24367394
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23707438
2012
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23142059
  • University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22093188
2011
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA. · Pubmed 21592278
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. · Pubmed 21456067
2008
  • The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 18487561
  • Department of GU Medical Oncology UT, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 18497043
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 18347159
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19138948
2017
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia; Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland; Josep M. Piulats, Institut Català d'Oncologia, Barcelona; Javier Puente, Hospital Clínico San Carlos, Madrid, Spain; Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar; Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile; Dirk Jaeger, University Hospital, Heidelberg, Germany; Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil; Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico; Lisa Sengeløv, Herlev Hospital, Herlev, Denmark; M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT; Arvind Varma, DOCS Inc, New York, NY; Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam; and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25155428
2014
  • Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Authors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, CanadaAuthors' Affiliations: Division of Hematology and Medical Oncology; Institute for Precision Medicine, New York Presbyterian; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; Department of Oncology, Memorial Sloan Kettering, New York, New York; Department of Pathology, University of Michigan, Ann Arbor, Michigan; Department of Oncology, The University of Texas MD Anderson Cancer Center; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; Prostate Cancer Foundation, Santa Monica, California; Department of Pathology, University of Washington, Seattle, Washington; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 24727321
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 25347368
  • Authors' Affiliations: Michigan Center for Translational Pathology; Departments of Pathology, Radiation Oncology, Internal Medicine, Pharmacology, and Urology; Comprehensive Cancer Center; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas; Department of Urology, Institute of Prostate Cancer and LeFrak Center For Robotic Surgery; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York Presbyterian Hospitals, New York, New York; Departments of Cancer Biology, Urology, and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania; and Centre for Integrative Biology, University of Trento, Trento, Italy. · Pubmed 24473064
2013
  • Department of Genitourinary Medical Onology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 24211163
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-3721, USA. · Pubmed 23649003
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 23526299
  • UT MD Anderson Cancer Center, Genitourinary Medical Oncology, Houston, Texas 77030, USA. · Pubmed 23371521
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23339185
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 23102837
2012
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1374, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 22184395
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21976132
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030-4009, USA. · Pubmed 21821830
  • Department of Genitourinary Medical Oncology and David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23300537
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23166609
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler, Houston, TX 77230, USA. · Pubmed 23033003
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-3721, USA. · Pubmed 22809348
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Box 1374, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22805323
  • Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77030-3721, USA. · Pubmed 22593245
  • Department of Genitourinary Medical Oncology, The David Koch Center for Applied Research of Genitourinary Cancers, The Stanford Alexander Tissue Derivatives Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22457212
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22156612
  • Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21681775
2011
  • University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Clinical Research Building (T7.3891), 1515 Holcombe Blvd, Unit 0018-4, Houston, TX 77030, USA. · Pubmed 22035268
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 21917607
  • The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030-3721, USA. · Pubmed 21606419
  • Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 22586648
  • Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Pubmed 22194926
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 21707705
2010
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20551894
  • Department of Genitourinary Medical Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19581923
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21044312
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20564322
  • Departments of Molecular Pathology, Genitourinary Medical Oncology, and System Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20484040
  • Department of Genitourinary Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 20386565
  • University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19853370
2009
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77239-1439, USA. · Pubmed 19414670
  • Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19244175
  • Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 19855158
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 19652704
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 19551858
  • Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19202079
2008
  • Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, 1155 Pressler, CPB7.3462, Houston, TX 77030, USA. · Pubmed 19029421
  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, 1155 Pressler, Houston, TX 77030, USA. · Pubmed 18841158
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18708358
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 18618013
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18559590
  • Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18490922
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA. · Pubmed 17700537
2007
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3721, USA. · Pubmed 17879948
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 17317833
  • Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17971530
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 17908974
  • Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 17638862
University of Athens
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
2013
  • Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Pubmed 22753310
2010
  • Department of Genitourinary Medical Oncology and David H Koch Center for Applied Research of Genitourinary Cancers, University of Athens, Athens, Greece. · Pubmed 20145177
Unspecified
2016
  • Michigan Center for Translational Pathology; Department of Pathology; Comprehensive Cancer Center. · Michigan Center for Translational Pathology; Department of Radiation Oncology; Comprehensive Cancer Center. · Department of Urology. · Michigan Center for Translational Pathology; Howard Hughes Medical Institute. · Department of Radiation Oncology. · Department of Genitourinary Medical Oncology; David H. Koch Center for Applied Research of Genitourinary Cancers. · Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry. · Department of Urology; Comprehensive Cancer Center. · Department of Internal Medicine. · Comprehensive Cancer Center; Department of Internal Medicine. · Michigan Center for Translational Pathology; Department of Pathology; Department of Urology; Comprehensive Cancer Center. · Michigan Center for Translational Pathology; Department of Pathology; Department of Urology; Howard Hughes Medical Institute; Comprehensive Cancer Center. Electronic address: · Michigan Center for Translational Pathology; Department of Urology; Comprehensive Cancer Center. · Pubmed 26806347
2015
  • Departments of Genitourinary Medical Oncology. · University of New Mexico Cancer Center and Divisions of Molecular Medicine, and. · David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; · Biostatistics, and. · Pathology and. · Harvard Medical School and Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215; and · University of New Mexico Cancer Center and Divisions of Molecular Medicine, and · University of New Mexico Cancer Center and Divisions of Hematology and Medical Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131 · Pubmed 25675522
Miscellaneous institutions in Houston
2015
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. Electronic address: · Pubmed 24882673
63 Other Locations Show
Yearly article counts 0815161116161489118